NorthWest Biotherapeutics Inc (NWBO)

[Doc logic]

skitahoe,

The science is getting to the point where biomarkers and disease state will determine the proper course of action without much guessing. I believe that the IFR funding pathway is now kind of being used as the beginning of this kind of focused and personalized treatment intervention. The early info obviously came from the Phase 3 L trial, other combo trials and Specials Program patients. What happens next seems to be real world data gathering from specific treatment regimens being agreed to based on likelihood of need and response. If this is what happens then cancer treatment will be looking quite different in the not too distant future and your experience at City of Hope will look more like the norm than the outlier with the exception that there won’t be as much guessing. That will be mostly replaced with a series of normalized steps; ). Best wishes.